Summary
- Current Price
- As of today, SCYX price is $0.85, down -7.42% in the most recent trading session on
- Current Price All-Time High
- SCYX price is currently -99.43% below its historical high of $150.00 set on
- Market Cap
- SCYX current market cap is $67M, up +83.23% over the past 365 days
- PE Ratio
- SCYX PE ratio is unknown
- Revenue
- SCYX current annual revenue is $20.60M, up +449.95% year-over-year
- Next Earnings
- The next earnings release for SCYX is on
Profile
| Metric | Value |
|---|---|
| Full Name | SCYNEXIS, Inc. |
| Ticker | NASDAQ: SCYX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | scynexis.com |
| Employees | 28 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.85 | ||
| Price, 1D Change | -7.42% | |
| $67M | ||
| - | ||
| - | ||
| 0.70 | ||
| $21M | ||
| Revenue, 1Y Change | +449.95% | |
| -$0.17 | ||
| EPS, 1Y Change | +60.71% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.17 | ||
| EPS Estimate | N/A | -$0.37 |
| EPS Est. Change | N/A | -116.53% |
| $20.60M | ||
| Revenue Estimate | N/A | $1.15M |
| Revenue Est. Change | N/A | -94.40% |
| $0.85 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +371.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.43 | -$0.44 | -1.27% | |
| -$0.31 | -$0.17 | +44.97% | |
| -$0.37 | N/A | -116.53% | |
| -$0.22 | N/A | -25.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.96M | $3.75M | -71.09% | |
| $9.94M | $20.60M | +107.18% | |
| $1.15M | N/A | -94.40% | |
| $6.68M | N/A | -67.59% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -10.00% | ||
| -69.17% | ||
| +83.23% | ||
| -32.93% | ||
| +449.95% | ||
| +304.66% | ||
| +60.71% | ||
| +88.30% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.85 | ||
| $0.80 | ||
| SMA 200 vs Price | -5.61% | |
| $0.93 | ||
| SMA 50 vs Price | +9.40% | |
| 0.70 | ||
| $0.06 | ||
| 43.81 | ||
| 59.14% | ||
| 78.37% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $20.60M | ||
| -$0.17 | ||
| $0.00 | ||
| 0.00% | ||
| -$16.07M | ||
| -78.03% | ||
| -$8.61M | ||
| -41.79% | ||
| -$16.07M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 7.04 | ||
| 7.04 | ||
| - | ||
| 4 | ||
| -4.79 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.27 | ||
| 1.36 | ||
| -1.83 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $49.38M | ||
| $40.11M | ||
| $59.03M | ||
| $40.37M | ||
| $9.65M | ||
| $5.73M | ||
| $2.18M | ||
| $483.00K | ||
| $2.23M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $29.21M | ||
| $16.07M | ||
| - | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.28M | ||
| $24.31M | ||
| -$14.17M | ||
| $0.00 | ||
| -$5.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | → | |
| Ladenburg Thalmann | ||
| Guggenheim | ||
| Guggenheim | ||
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Aegis Capital | ||
| Aegis Capital |
Analyst sentiment
Institutional ownership
Screeners with SCYX
FAQ
What is the ticker symbol for SCYNEXIS, Inc.?
The ticker symbol for SCYNEXIS, Inc. is NASDAQ:SCYX
Does SCYNEXIS, Inc. pay dividends?
No, SCYNEXIS, Inc. does not pay dividends
What sector is SCYNEXIS, Inc. in?
SCYNEXIS, Inc. is in the Healthcare sector
What industry is SCYNEXIS, Inc. in?
SCYNEXIS, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is SCYNEXIS, Inc. based in?
SCYNEXIS, Inc. is headquartered in United States
When did SCYNEXIS, Inc. go public?
SCYNEXIS, Inc. initial public offering (IPO) was on May 2, 2014
Is SCYNEXIS, Inc. in the S&P 500?
No, SCYNEXIS, Inc. is not included in the S&P 500 index
Is SCYNEXIS, Inc. in the NASDAQ 100?
No, SCYNEXIS, Inc. is not included in the NASDAQ 100 index
Is SCYNEXIS, Inc. in the Dow Jones?
No, SCYNEXIS, Inc. is not included in the Dow Jones index
When was SCYNEXIS, Inc. last earnings report?
SCYNEXIS, Inc.'s most recent earnings report was on March 4, 2026
When does SCYNEXIS, Inc. report earnings?
The next expected earnings date for SCYNEXIS, Inc. is May 15, 2026
Data Sources & References
- SCYX Official Website www.scynexis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1178253/000117825326000007/0001178253-26-000007-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178253/000117825326000007/0001178253-26-000007-index.htm
- SCYX Profile on Yahoo Finance finance.yahoo.com/quote/SCYX
- SCYX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/scyx